Evidence-based Cardiology, Second Edition

Copyright © BMJ Books 1998, 2003

Evidence-based Cardiology, Second Edition

Editor(s): Salim Yusuf, John A Cairns, A John Camm, Ernest L Fallen, Bernard J Gersh

Published Online: 4 OCT 2007

Print ISBN: 9780727916990

Online ISBN: 9780470986882

DOI: 10.1002/9780470986882

About this Book

Product Information

About The Product

This second editionis a ground-breaking clinical text with a strong emphasis on rigorous evidence. Leaders in the field discuss best practice in the light of systematic reviews and randomised control trials, and how best to treat where the information is less clear. Case histories provide intriguing discussions on how to apply the evidence in real life situations.

Evidence-based Cardiology also includes free access to the latest evidence, which is automatically posted on a companion website.

Table of contents

    1. You have free access to this content
      Frontmatter (pages i–xxiii)

  2. Part I: General Concepts and Critical Appraisal

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 1–2)

    2. Chapter 1

      What is Evidence-Based Cardiology? (pages 3–13)

      PJ Devereaux, R Brian Haynes and Salim Yusuf

    3. Chapter 2

      A Critical Appraisal of the Cardiovascular History and Physical Examination (pages 14–23)

      Akbar Panju, Brenda Hemmelgarn, Jim Nishikawa, Deborah Cook and Allan Kitching

    4. Chapter 3

      Obtaining Incremental Information from Diagnostic Tests (pages 24–33)

      Raymond J Gibbons

    5. Chapter 4

      Clinical Trials and Meta-Analysis (pages 34–39)

      Colin Baigent

    6. Chapter 5

      Finding Current Best Evidence to Practice Evidence-Based Cardiology (pages 40–45)

      Dereck L Hunt, K Ann McKibbon and R Brian Haynes

    7. Chapter 6

      Understanding Concepts Related to Health Economics (pages 46–55)

      Mark Hlatky

    8. Chapter 7

      Introduction to Decision Analysis (pages 56–70)

      Kevin A Schulman, Henry A Glick and Allan S Detsky

    9. Chapter 8

      Assessing and Changing Cardiovascular Clinical Practices (pages 71–88)

      C David Naylor and David A Alter

  3. Part II: Prevention of Cardiovascular Diseases

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 89–90)

    2. Chapter 9

      Global Perspective on Cardiovascular Disease (pages 91–102)

      K Srinath Reddy

    3. Chapter 10

      Tobacco: Global Burden and Community Solutions (pages 103–113)

      Terry F Pechacek, Samira Asma, Nicole Blair and Michael P Eriksen

    4. Chapter 11

      Tobacco and Cardiovascular Disease: Achieving Smoking Cessation (pages 114–120)

      Godfrey H Fowler

    5. Chapter 12

      Lipids and Cardiovascular Disease (pages 121–129)

      Malcolm Law

    6. Chapter 13

      Use of Lipid Lowering Agents in the Prevention of Cardiovascular Disease (pages 130–145)

      Jeffrey L Probstfield

    7. Chapter 14

      Blood Pressure and Cardiovascular Disease (pages 146–160)

      Curt D Furberg and Bruce M Psaty

    8. Chapter 15

      Glucose Abnormalities and Cardiovascular Disease: “Dysglycemia” as an Emerging Cardiovascular Risk Factor (pages 161–169)

      Sarah E Capes and Hertzel C Gerstein

    9. Chapter 16

      Physical Activity and Exercise in Cardiovascular Disease Prevention and Rehabilitation (pages 170–180)

      Erika S Froelicher, Roberta K Oka and Gerald F Fletcher

    10. Chapter 17

      Psychosocial Factors in the Primary and Secondary Prevention of Coronary Heart Disease: An Updated Systematic Review of Prospective Cohort Studies (pages 181–218)

      Harry Hemingway, Hannah Kuper and Michael Marmot

    11. Chapter 18

      Emerging Approaches in Cardiovascular Prevention (pages 219–230)

      Eva M Lonn, Marek Smieja and Salim Yusuf

    12. Chapter 19

      Obesity (pages 231–243)

      Arya M Sharma

    13. Chapter 20

      Postmenopausal Hormone Therapy and Cardiovascular Disease (pages 244–258)

      Jacques E Rossouw

    14. Chapter 21

      Ethnicity and Cardiovascular Disease (pages 259–278)

      Sonia S Anand, Stephanie Ounpuu and Salim Yusuf

    15. Chapter 22

      The Fetal Origins of Coronary Heart Disease (pages 279–286)

      David JP Barker

    16. Chapter 23

      Molecular Genetics of Cardiovascular Disorders (pages 287–299)

      AJ Marian and Robert Roberts

    17. Chapter 24

      Cost Effectiveness of Prevention of Cardiovascular Disease (pages 300–308)

      Daniel B Mark

    18. Chapter 25

      Diet and Cardiovascular Disease (pages 309–325)

      K Srinath Reddy

  4. Part IIIa: Specific Cardiovascular Disorders: Stable Coronary Artery Disease

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 327–328)

    2. Chapter 26

      Anti-Ischemic Drugs (pages 329–338)

      Lionel H Opie

    3. Chapter 27

      Impact of Revascularization Procedures in Chronic Coronary Artery Disease on Clinical Outcomes: A Critical Review of the Evidence (pages 339–359)

      Charanjit S Rihal, Dominic Raco, Bernard J Gersh and Salim Yusuf

    4. Chapter 28

      Adjunctive Medical Therapy in Percutaneous Coronary Intervention (pages 360–370)

      James L Velianou, Ronald R Van Der Wieken and Maarten M Simoons

    5. Chapter 29

      Restenosis: Etiologies and Prevention (pages 371–394)

      Giuseppe Sangiorgi, David R Holmes and Robert S Schwartz

  5. Part IIIb: Specific Cardiovascular Disorders: Acute Ischemic Syndromes and Acute Myocardial Infarction

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 395–396)

    2. Chapter 30

      Acute non-ST-segment Elevation Coronary Syndromes: Unstable Angina and non-ST-segment Elevation Myocardial Infarction (pages 397–425)

      Pierre Theroux and John A Cairns

    3. Chapter 31

      Fibrinolytic Therapy (pages 426–443)

      James S Zebrack and Jeffrey L Anderson

    4. Chapter 32

      Mechanical Reperfusion Strategies in Patients Presenting with Acute Myocardial Infarction (pages 444–455)

      Sanjaya Khanal and W Douglas Weaver

    5. Chapter 33

      Adjunctive Antithrombotic Therapy for St-Elevation Acute Myocardial Infarction (pages 456–476)

      John K French and Harvey D White

    6. Chapter 34

      Pain Relief, General Management, and Other Adjunctive Treatments (pages 477–487)

      Aldo P Maggioni, Roberto Latini, Gianni Tognoni and Peter Sleight

    7. Chapter 35

      Complications After Myocardial Infarction (pages 488–506)

      Peter L Thompson and Barry Mckeown

    8. Chapter 36

      An Integrated Approach to the Management of Patients After the Early Phase of the Acute Coronary Syndromes (pages 507–516)

      Desmond G Julian

  6. Part IIIc: Specific Cardiovascular Disorders: Atrial Fibrillation and Supraventricular Tachycardia

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 517–518)

    2. Chapter 37

      Atrial Fibrillation: Antiarrhythmic Therapy (pages 519–547)

      Harry JGM Crijns, Isabelle C Van Gelder, Irina Savelieva and A John Camm

    3. Chapter 38

      Atrial Fibrillation: Antithrombotic Therapy (pages 548–555)

      John A Cairns

    4. Chapter 39

      Atrial Fibrillation: Non-Pharmacologic Therapies (pages 556–566)

      Sanjeev Saksena and Andrew J Einstein

    5. Chapter 40

      Supraventricular Tachycardia: Drugs v Ablation (pages 567–574)

      Neil R Grubb and Peter Kowey

  7. Part IIId: Specific Cardiovascular Disorders: Ventricular Arrhythmias, Bradyarrhythmias and Cardiac Arrest

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 575–576)

    2. Chapter 41

      Prevention and Treatment of Life-Threatening Ventricular Arrhythmia and Sudden Death (pages 577–586)

      Eugene Crystal, Stuart J Connolly and Paul Dorian

    3. Chapter 42

      Impact of Pacemakers: When and What Kind? (pages 587–618)

      William D Toff and A John Camm

    4. Chapter 43

      Syncope (pages 619–633)

      David G Benditt, Cengiz Ermis, Keith G Lurie and Scott Sakaguchi

    5. Chapter 44

      Cardiopulmonary Resuscitation (pages 634–640)

      Nicola E Schiebel and Roger D White

  8. Part IIIe: Specific Cardiovascular Disorders: Left Ventricular Dysfunction

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 641–642)

    2. Chapter 45

      Prevention of Congestive Heart Failure and Treatment of Asymptomatic Left Ventricular Dysfunction (pages 643–658)

      RS Mckelvie, CR Benedict and Salim Yusuf

    3. Chapter 46

      Management of Overt Heart Failure (pages 659–680)

      Bert Andersson and Karl Swedberg

    4. Chapter 47

      Acute Myocarditis and Dilated Cardiomyopathy (pages 681–702)

      Barbara A Pisani and John F Carlquist

    5. Chapter 48

      Hypertrophic Cardiomyopathy (pages 703–717)

      Perry M Elliott, Rajesh Thaman and William J Mckenna

    6. Chapter 49

      Other Cardiomyopathies (pages 718–732)

      José A Marin-Neto, Marcus ViníCius Simões and Benedito Carlos Maciel

  9. Part IIIf: Specific Cardiovascular Disorders: Pericardial Disease

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 733–734)

    2. Chapter 50

      Pericardial Disease: An Evidence-Based Approach to Diagnosis and Treatment (pages 735–748)

      Bongani M Mayosi, James A Volmink and Patrick J Commerford

  10. Part IIIg: Specific Cardiovascular Disorders: Valvular Heart Disease

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 749–750)

    2. Chapter 51

      Rheumatic Heart Disease: Prevention and Acute Treatment (pages 751–757)

      Edmund AW Brice and Patrick J Commerford

    3. Chapter 52

      Mitral Valve Disease: Indications for Surgery (pages 758–766)

      Blasé A Carabello

    4. Chapter 53

      Indications for Surgery in Aortic Valve Disease (pages 767–781)

      Heidi M Connolly and Shahbudin H Rahimtoola

    5. Chapter 54

      Balloon Valvuloplasty: Aortic Valve (pages 782–795)

      Daniel J Diver and Jeffrey A Breall

    6. Chapter 55

      Balloon Valvuloplasty: Mitral Valve (pages 796–808)

      Zoltan G Turi

    7. Chapter 56

      Valve Repair and Choice of Valves (pages 809–816)

      Paul J Pearson and Hartzell V Schaff

    8. Chapter 57

      Diagnosis and Management of Infective Endocarditis (pages 817–831)

      David T Durack and Michael L Towns

    9. Chapter 58

      Antithrombotic Therapy after Heart Valve Replacement (pages 832–836)

      Alexander GG Turpie and Walter Ageno

  11. Part IIIh: Specific Cardiovascular Disorders: Other Conditions

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 837–838)

    2. Chapter 59

      Treatment of Patients with Stroke (pages 839–852)

      Craig S Anderson

    3. Chapter 60

      Heart Disease and Pregnancy (pages 853–863)

      Samuel C Siu and Jack M Colman

    4. Chapter 61

      Venous Thromboembolic Disease (pages 864–876)

      Clive Kearon, Jeffrey S Ginsberg and Jack Hirsh

    5. Chapter 62

      Peripheral Vascular Disease (pages 877–886)

      Jesper Swedenborg and Jan Östergren

  12. Part IV: Clinical Applications

    1. You have free access to this content
      Grading of Recommendations and Levels of Evidence Used in Evidence-based Cardiology (pages 887–888)

    2. Chapter 63

      Clinical Applications of External Evidence (pages 889–891)

      Ernest L Fallen and Salim Yusuf

    3. Chapter 64

      Stable Angina: Choice of PCI v CABG v Drugs (pages 892–895)

      Douglas A Holder

    4. Chapter 65

      Acute Coronary Syndromes (pages 896–901)

      George J Philippides

    5. Chapter 66

      Acute Myocardial Infarction (pages 902–905)

      Bryan F Dias and Ernest L Fallen

    6. Chapter 67

      Postmyocardial Infarction: Preventive Measures (pages 906–908)

      Ernest L Fallen

    7. Chapter 68

      Metabolic Risk and Secondary Prevention of Coronary Disease (pages 909–911)

      Jacques Genest

    8. Chapter 69

      Peripheral Vascular Disease with Suspect Coronary Artery Disease (pages 912–914)

      Peter C Spittell

    9. Chapter 70

      Heart Failure (pages 915–920)

      Michael M Givertz

    10. Chapter 71

      Atrial Fibrillation (pages 921–924)

      Michael Klein

    11. Chapter 72

      Ventricular Dysrhythmias: Pharmacologic v Non-Pharmacologic Treatment (pages 925–930)

      L Brent Mitchell

    12. Chapter 73

      Bradyarrhythmias: Choice of Pacemaker (pages 931–933)

      John A Boone

    13. Chapter 74

      Valvular Heart Disease: Timing of Surgery (pages 934–937)

      Adrian P Banning and Brian B Gribbin

    1. You have free access to this content
      Index (pages 939–968)

SEARCH